Myelofibrosis Clinical Trials
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
I
I
Recruiting
- Myelofibrosis
- +5 more
- Birmingham, Alabama
- +26 more
2022-03-30
Mar 30, 2022C
N
Completed
- Chronic Myelogenous Leukemia
- +9 more
- Fludarabine
- +3 more
- Atlanta, GeorgiaNorthside Hospital
2022-04-04
Apr 4, 2022S
Recruiting
- Myelofibrosis
- Gainesville, Florida
- +10 more
2022-04-04
Apr 4, 2022T
Recruiting
- Acute Lymphoblastic Leukemia
- +15 more
- Hematopoietic Cell Transplantation
- +7 more
- Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
2022-04-01
Apr 1, 2022I
Active, not recruiting
- Myelofibrosis
- +2 more
- New Orleans, Louisiana
- +20 more
2022-03-22
Mar 22, 2022K
Recruiting
- Myelofibrosis
- Selinexor
- Physician's Choice Treatment
- Pasadena, California
- +14 more
2022-04-01
Apr 1, 2022M
Recruiting
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- +10 more
- Anti-PR1/HLA-A2 Monoclonal Antibody Hu8F4
- +2 more
- Houston, TexasM D Anderson Cancer Center
2022-03-30
Mar 30, 2022C
Recruiting
- Myeloproliferative Disorders
- +4 more
- ACE-536
- Placebo
- La Jolla, California
- +149 more
2022-03-18
Mar 18, 2022N
Active, not recruiting
- Acute Myeloid Leukemia
- +9 more
- Carboplatin
- +3 more
- Los Angeles, California
- +5 more
2022-03-30
Mar 30, 2022C
Recruiting
- Primary Myelofibrosis
- +2 more
- FEDRATINIB
- Best Available Therapy (BAT)
- Darlinghurst, New South Wales, Australia
- +109 more
2022-03-15
Mar 15, 2022I
Completed
- Myelofibrosis
- +3 more
- Ann Arbor, Michigan
- +4 more
2022-03-28
Mar 28, 2022I
Recruiting
- Myelofibrosis
- +3 more
- parsaclisib
- +2 more
- Berkeley, California
- +178 more
2022-03-22
Mar 22, 2022S
Recruiting
- Myelofibrosis
- Antwerpen, Belgium
- +11 more
2022-03-21
Mar 21, 2022T
Recruiting
- Myelofibrosis
- Aurora, Colorado
- +63 more
2022-03-05
Mar 5, 2022C
Recruiting
- Myelofibrosis
- Hematopoietic Stem Cell Transplant
- Minneapolis, MinnesotaCenter for International Blood and Marrow Transplant Research
2022-03-17
Mar 17, 2022R
Recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +36 more
- Cyclophosphamide
- +4 more
- Buffalo, New YorkRoswell Park Cancer Institute
2022-03-17
Mar 17, 2022C
Recruiting
- Myelofibrosis
- +13 more
- Phoenix, Arizona
- +54 more
2022-03-04
Mar 4, 2022K
Recruiting
- Myelofibrosis
- KER-050 monotherapy
- KER-050 in combination with ruxolitinib
- Tweed Heads, New South Wales, Australia
- +4 more
2022-03-02
Mar 2, 2022F
Recruiting
- Acute Biphenotypic Leukemia
- +18 more
- Cyclophosphamide
- +8 more
- Aurora, Colorado
- +2 more
2022-03-02
Mar 2, 2022G
Recruiting
- Myelofibrosis
- Imetelstat
- Best Available Therapy (BAT)
- La Jolla, California
- +169 more
2022-03-14
Mar 14, 2022S
Not yet recruiting
- Myelofibrosis
- Jaktinib Hydrochloride Tablet
- (no location specified)
2022-03-03
Mar 3, 2022T
Not yet recruiting
- Myelofibrosis
- +3 more
- (no location specified)
2022-03-05
Mar 5, 2022I
Recruiting
- Myelofibrosis
- Aurora, Colorado
- +4 more
2022-03-08
Mar 8, 2022